Cargando…
Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease
BACKGROUND: Non-obese diabetic (NOD) mice develop Sjögren's-like disease (SS-like) with loss of saliva flow and increased lymphocytic infiltrates in salivary glands (SGs). There are recent reports using multipotent mesenchymal stromal cells (MSCs) as a therapeutic strategy for autoimmune diseas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369846/ https://www.ncbi.nlm.nih.gov/pubmed/22685592 http://dx.doi.org/10.1371/journal.pone.0038615 |
_version_ | 1782235092355121152 |
---|---|
author | Khalili, Saeed Liu, Younan Kornete, Mara Roescher, Nienke Kodama, Shohta Peterson, Alan Piccirillo, Ciriaco A. Tran, Simon D. |
author_facet | Khalili, Saeed Liu, Younan Kornete, Mara Roescher, Nienke Kodama, Shohta Peterson, Alan Piccirillo, Ciriaco A. Tran, Simon D. |
author_sort | Khalili, Saeed |
collection | PubMed |
description | BACKGROUND: Non-obese diabetic (NOD) mice develop Sjögren's-like disease (SS-like) with loss of saliva flow and increased lymphocytic infiltrates in salivary glands (SGs). There are recent reports using multipotent mesenchymal stromal cells (MSCs) as a therapeutic strategy for autoimmune diseases due to their anti-inflammatory and immunomodulatory capabilities. This paper proposed a combined immuno- and cell-based therapy consisting of: A) an injection of complete Freund's adjuvant (CFA) to eradicate autoreactive T lymphocytes, and B) transplantations of MSCs to reselect lymphocytes. The objective of this was to test the effectiveness of CD45(−)/TER119(−) cells (MSCs) in re-establishing salivary function and in reducing the number of lymphocytic infiltrates (foci) in SGs. The second objective was to study if the mechanisms underlying a decrease in inflammation (focus score) was due to CFA, MSCs, or CFA+MSCs combined. METHODOLOGY/PRINCIPAL FINDINGS: Donor MSCs were isolated from bones of male transgenic eGFP mice. Eight week-old female NOD mice received one of the following treatments: insulin, CFA, MSC, or CFA+MSC (combined therapy). Mice were followed for 14 weeks post-therapy. CD45(−)/TER119(−) cells demonstrated characteristics of MSCs as they were positive for Sca-1, CD106, CD105, CD73, CD29, CD44, negative for CD45, TER119, CD11b, had high number of CFU-F, and differentiated into osteocytes, chondrocytes and adipocytes. Both MSC and MSC+CFA groups prevented loss of saliva flow and reduced lymphocytic infiltrations in SGs. Moreover, the influx of T and B cells decreased in all foci in MSC and MSC+CFA groups, while the frequency of Foxp3(+) (T(reg)) cell was increased. MSC-therapy alone reduced inflammation (TNF-α, TGF-β), but the combination of MSC+CFA reduced inflammation and increased the regenerative potential of SGs (FGF-2, EGF). CONCLUSIONS/SIGNIFICANCE: The combined use of MSC+CFA was effective in both preventing saliva secretion loss and reducing lymphocytic influx in salivary glands. |
format | Online Article Text |
id | pubmed-3369846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-33698462012-06-08 Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease Khalili, Saeed Liu, Younan Kornete, Mara Roescher, Nienke Kodama, Shohta Peterson, Alan Piccirillo, Ciriaco A. Tran, Simon D. PLoS One Research Article BACKGROUND: Non-obese diabetic (NOD) mice develop Sjögren's-like disease (SS-like) with loss of saliva flow and increased lymphocytic infiltrates in salivary glands (SGs). There are recent reports using multipotent mesenchymal stromal cells (MSCs) as a therapeutic strategy for autoimmune diseases due to their anti-inflammatory and immunomodulatory capabilities. This paper proposed a combined immuno- and cell-based therapy consisting of: A) an injection of complete Freund's adjuvant (CFA) to eradicate autoreactive T lymphocytes, and B) transplantations of MSCs to reselect lymphocytes. The objective of this was to test the effectiveness of CD45(−)/TER119(−) cells (MSCs) in re-establishing salivary function and in reducing the number of lymphocytic infiltrates (foci) in SGs. The second objective was to study if the mechanisms underlying a decrease in inflammation (focus score) was due to CFA, MSCs, or CFA+MSCs combined. METHODOLOGY/PRINCIPAL FINDINGS: Donor MSCs were isolated from bones of male transgenic eGFP mice. Eight week-old female NOD mice received one of the following treatments: insulin, CFA, MSC, or CFA+MSC (combined therapy). Mice were followed for 14 weeks post-therapy. CD45(−)/TER119(−) cells demonstrated characteristics of MSCs as they were positive for Sca-1, CD106, CD105, CD73, CD29, CD44, negative for CD45, TER119, CD11b, had high number of CFU-F, and differentiated into osteocytes, chondrocytes and adipocytes. Both MSC and MSC+CFA groups prevented loss of saliva flow and reduced lymphocytic infiltrations in SGs. Moreover, the influx of T and B cells decreased in all foci in MSC and MSC+CFA groups, while the frequency of Foxp3(+) (T(reg)) cell was increased. MSC-therapy alone reduced inflammation (TNF-α, TGF-β), but the combination of MSC+CFA reduced inflammation and increased the regenerative potential of SGs (FGF-2, EGF). CONCLUSIONS/SIGNIFICANCE: The combined use of MSC+CFA was effective in both preventing saliva secretion loss and reducing lymphocytic influx in salivary glands. Public Library of Science 2012-06-07 /pmc/articles/PMC3369846/ /pubmed/22685592 http://dx.doi.org/10.1371/journal.pone.0038615 Text en Khalili et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Khalili, Saeed Liu, Younan Kornete, Mara Roescher, Nienke Kodama, Shohta Peterson, Alan Piccirillo, Ciriaco A. Tran, Simon D. Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title | Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title_full | Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title_fullStr | Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title_full_unstemmed | Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title_short | Mesenchymal Stromal Cells Improve Salivary Function and Reduce Lymphocytic Infiltrates in Mice with Sjögren's-Like Disease |
title_sort | mesenchymal stromal cells improve salivary function and reduce lymphocytic infiltrates in mice with sjögren's-like disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3369846/ https://www.ncbi.nlm.nih.gov/pubmed/22685592 http://dx.doi.org/10.1371/journal.pone.0038615 |
work_keys_str_mv | AT khalilisaeed mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT liuyounan mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT kornetemara mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT roeschernienke mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT kodamashohta mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT petersonalan mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT piccirillociriacoa mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease AT transimond mesenchymalstromalcellsimprovesalivaryfunctionandreducelymphocyticinfiltratesinmicewithsjogrenslikedisease |